Protein G Sepharose® (ab193259)
Key features and details
- Sample type: Ascites Fluid, Cell culture media, Cell culture supernatant, Serum
Overview
-
Product name
Protein G Sepharose® -
Sample type
Cell culture supernatant, Serum, Cell culture media, Ascites Fluid -
Product overview
Contents:
Supplied as 50% slurry in 20% Ethanol.
Features:
High binding capacity: Binding of IgG >20 mg human or rabbit IgG/mL Protein G Sepharose®.
Minimal Leaching of the Ligand
Flow Rate Tested*: 2.07 mL/min.
*Test condition: = Calculations based on the time required to pass 18 mL of water through 2 mL settled beads (column diameter 1.5 cm).
Usage: Reusable for up to 10 times without significant loss of binding capacity.
These beads are for use in column purification. If used in batch purification, we recommend not exceeding 150 x g when centrifuging.
Store beads at 4°C.
The beads may be damaged above 40°C.
DO NOT FREEZE.
Wash beads 3 times with 3x bead volume of desired buffer before use.
Applications:
- Purification of monoclonal and polyclonal antibodies from culture media, serum, ascites fluid or hybridoma supernatants.
- Isolation of antibody/antigen complexes in immunoprecipitation experiments, since only the Fc region is involved in antibody binding and the Fab region is available for binding antigen.
Sepharose is a registered trademark of GE Healthcare
-
Notes
This product is manufactured by BioVision, an Abcam company and was previously called 6511 Protein G Sepharose. 6511-100 is the same size as the 100 ml size of ab193259.
Protein G Sepharose® beads are prepared by covalently coupling recombinant Protein G to 6% cross-linked Sepharose® beads. Protein G is a genetically engineered protein containing three IgG-binding regions of native Protein G. The cell wall binding region, albumin binding region and other non-specific regions have been eliminated from the recombinant Protein G to ensure maximum specific IgG binding. The coupling technique is optimized to give a higher binding capacity for IgG and minimum leaching of recombinant Protein G. The IgG binding capacity of Protein G Sepharose® is >20 mg of human or rabbit IgG per mL of wet beads. Protein G Sepharose® beads display high chemical and physical stability as well as high flow rate, hydrophilicity and high gel strength. This product can be used for IgG purification and immunoprecipitation.
-
Tested applications
Suitable for: Purification, IPmore details
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 1 ml 5 ml 25 ml 100 ml Protein G Sepharose® 1 x 1ml 1 x 5ml 1 x 25ml 1 x 100ml -
Research areas
Associated products
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab193259 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| Purification |
Use at an assay dependent concentration.
Purification of monoclonal and polyclonal antibodies from culture media, serum, ascites fluid or hybridoma supernatants. |
|
| IP |
Use at an assay dependent concentration.
Isolation of antibody/antigen complexes in immunoprecipitation experiments, since only the Fc region is involved in antibody binding and the Fab region is available for binding antigen. |
| Notes |
|---|
|
Purification
Use at an assay dependent concentration. Purification of monoclonal and polyclonal antibodies from culture media, serum, ascites fluid or hybridoma supernatants. |
|
IP
Use at an assay dependent concentration. Isolation of antibody/antigen complexes in immunoprecipitation experiments, since only the Fc region is involved in antibody binding and the Fab region is available for binding antigen. |
Datasheets and documents
-
SDS download
-
Datasheet download
References (6)
ab193259 has been referenced in 6 publications.
- Filippou A et al. ANO1 Expression Orchestrates p27Kip1/MCL1-Mediated Signaling in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 13:N/A (2021). PubMed: 33803266
- Miccoli A et al. Molecular, Cellular and Functional Analysis of TR? Chain along the European Sea Bass Dicentrarchus labrax Development. Int J Mol Sci 22:N/A (2021). PubMed: 33806063
- Sergeeva O et al. Modification of Adenosine196 by Mettl3 Methyltransferase in the 5'-External Transcribed Spacer of 47S Pre-rRNA Affects rRNA Maturation. Cells 9:N/A (2020). PubMed: 32344536
- Fefilova A et al. Murine Long Noncoding RNA Morrbid Contributes in the Regulation of NRAS Splicing in Hepatocytes In Vitro. Int J Mol Sci 21:N/A (2020). PubMed: 32764370
- Mohan HM et al. Calreticulin enhances the secretory trafficking of a misfolded a-1-antitrypsin. J Biol Chem 295:16754-16772 (2020). PubMed: 32978262
- DeLeo FR et al. Survival of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 in Human Blood. Antimicrob Agents Chemother 61:N/A (2017). Human . PubMed: 28115349